Annual Revenue
$42.81 M
+$16.91 M+65.28%
31 December 2023
Summary:
Pieris Pharmaceuticals annual revenue is currently $42.81 million, with the most recent change of +$16.91 million (+65.28%) on 31 December 2023. During the last 3 years, it has risen by +$13.49 million (+45.99%). PIRS annual revenue is now -7.50% below its all-time high of $46.28 million, reached on 31 December 2019.PIRS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Pieris Pharmaceuticals quarterly revenue is not available.PIRS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Pieris Pharmaceuticals TTM revenue is not available.PIRS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PIRS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.3% | - | - |
| 3 y3 years | +46.0% | - | - |
| 5 y5 years | +47.1% | - | - |
PIRS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +65.3% | ||||
| 5 y | 5 years | -7.5% | +65.3% | ||||
| alltime | all time | -7.5% | >+9999.0% |
Pieris Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $53.00 K(-95.9%) | $40.93 M(-4.4%) |
| Dec 2023 | $42.81 M(+65.3%) | $1.30 M(-93.3%) | $42.81 M(-9.6%) |
| Sept 2023 | - | $19.52 M(-2.7%) | $47.36 M(+42.6%) |
| June 2023 | - | $20.05 M(+935.9%) | $33.21 M(+97.1%) |
| Mar 2023 | - | $1.94 M(-66.9%) | $16.85 M(-34.9%) |
| Dec 2022 | $25.90 M(-17.6%) | $5.85 M(+8.9%) | $25.90 M(-9.1%) |
| Sept 2022 | - | $5.37 M(+45.2%) | $28.50 M(+4.8%) |
| June 2022 | - | $3.70 M(-66.3%) | $27.19 M(+1.5%) |
| Mar 2022 | - | $10.99 M(+30.1%) | $26.77 M(-14.8%) |
| Dec 2021 | $31.42 M(+7.1%) | $8.44 M(+108.1%) | $31.42 M(+26.4%) |
| Sept 2021 | - | $4.06 M(+23.5%) | $24.85 M(+4.7%) |
| June 2021 | - | $3.29 M(-79.0%) | $23.73 M(-25.1%) |
| Mar 2021 | - | $15.63 M(+732.9%) | $31.70 M(+8.1%) |
| Dec 2020 | $29.32 M(-36.6%) | $1.88 M(-36.1%) | $29.32 M(-34.4%) |
| Sept 2020 | - | $2.94 M(-73.9%) | $44.72 M(-21.4%) |
| June 2020 | - | $11.25 M(-15.2%) | $56.91 M(+11.6%) |
| Mar 2020 | - | $13.26 M(-23.2%) | $50.99 M(+10.2%) |
| Dec 2019 | $46.28 M | $17.27 M(+14.1%) | $46.28 M(+36.4%) |
| Sept 2019 | - | $15.13 M(+183.8%) | $33.92 M(+25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $5.33 M(-37.6%) | $27.14 M(-19.0%) |
| Mar 2019 | - | $8.54 M(+73.9%) | $33.49 M(+15.1%) |
| Dec 2018 | $29.10 M(+15.1%) | $4.91 M(-41.1%) | $29.10 M(-31.3%) |
| Sept 2018 | - | $8.35 M(-28.6%) | $42.34 M(+11.7%) |
| June 2018 | - | $11.69 M(+181.6%) | $37.92 M(+35.0%) |
| Mar 2018 | - | $4.15 M(-77.1%) | $28.08 M(+11.1%) |
| Dec 2017 | $25.27 M(+333.5%) | $18.15 M(+362.2%) | $25.27 M(+156.6%) |
| Sept 2017 | - | $3.93 M(+111.9%) | $9.85 M(+46.8%) |
| June 2017 | - | $1.85 M(+38.0%) | $6.71 M(+13.2%) |
| Mar 2017 | - | $1.34 M(-50.7%) | $5.93 M(+1.7%) |
| Dec 2016 | $5.83 M(+127.5%) | $2.73 M(+247.3%) | $5.83 M(+11.0%) |
| Sept 2016 | - | $785.00 K(-26.8%) | $5.25 M(+7.8%) |
| June 2016 | - | $1.07 M(-13.9%) | $4.87 M(+28.2%) |
| Mar 2016 | - | $1.25 M(-41.9%) | $3.80 M(+48.8%) |
| Dec 2015 | $2.56 M(-43.5%) | $2.15 M(+427.4%) | $2.55 M(+527.4%) |
| Sept 2015 | - | $407.00 K | $407.00 K |
| Dec 2014 | $4.53 M(-54.1%) | - | - |
| Dec 2013 | $9.88 M(>+9900.0%) | - | - |
| June 2002 | $2300.00(+21.1%) | - | - |
| June 2001 | $1900.00 | - | - |
FAQ
- What is Pieris Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals annual revenue year-on-year change?
- What is the all time high quarterly revenue for Pieris Pharmaceuticals?
- What is the all time high TTM revenue for Pieris Pharmaceuticals?
What is Pieris Pharmaceuticals annual revenue?
The current annual revenue of PIRS is $42.81 M
What is the all time high annual revenue for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high annual revenue is $46.28 M
What is Pieris Pharmaceuticals annual revenue year-on-year change?
Over the past year, PIRS annual revenue has changed by +$16.91 M (+65.28%)
What is the all time high quarterly revenue for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high quarterly revenue is $20.05 M
What is the all time high TTM revenue for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high TTM revenue is $56.91 M